Abbvie (ABBV) says not in discussions with Revolution Medicines (RVMD)

The clarification from AbbVie that it is not in discussions with Revolution Medicines indicates that any potential M&A speculation is unfounded, likely alleviating short-term uncertainty in both stocks.

Newsquawk StaffPublished On the live feed at 10 more headlines followed before this page went public
Newsquawk headlinesUTC

Punchbowl reports that the State of the Union date of February 24th is firm, which US President Trump will deliver

US President Trump says has been informed by the Department of War that RTX (RTX) has been the least responsive to the needs of the Department of War

Abbvie (ABBV) says not in discussions with Revolution Medicines (RVMD)

BEA to use the average of September and November CPI to calculate October PCE price data

The US pushes ahead with plans to reopen embassy in Venezuela

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This lack of dialogue suggests AbbVie’s current focus may be elsewhere, which could impact investor sentiment and stock performance in the biotechnology sector. As a result, keep an eye on market reactions, particularly for AbbVie as it could signal shifts in strategic priorities.

Related headlines

The whole workspace, free to try.

Try it free